2Q26 Quick Take: Imcivree Beat, HO Launch Momentum Building and RM-718 Data in HO Positive-20260804
On this morning's call (8:00am ET; Webcast here), we expect key focus areas to include: | M Downloaded by zouguanzhong@cramc.hk | Not for redistribution without written consent of Morgan Stanley | | | | --- | --- | --- | --- | | | | | Update | | August 4, 2026 11:52 AM GMT | | | | | Rhythm Pharmaceuticals Inc North America | Morgan Stanley & Co. LLC Michael E Ulz | | | | | Equity Analyst | | | | 2Q26 Quick Take: Imcivree Beat, | | Mike.Ulz@morganstanley.com | +1 212 761-4650 | | | Rohit Bhasin | | | | | Res ...